Has Michael Kosmo received payments from drug or device companies?

Yes. Drug and device makers reported $708,855 in general payments to Michael Kosmo across 564 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Michael Kosmo did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Michael Kosmo come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Michael Kosmo

Hematology & Oncology · Escondido, CANPI 1891742847

Payments from drug & device makers

$708,855in general payments, 2019–2025

Across 564 payments — averaging $1256.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Merck$512K
Eli Lilly$123K
Beigene, Ltd.$37K
Pfizer$16K
Incyte Corporation$15K
Amgen$718
plus $6K from 49 others

$17,183in research payments, 2019–2025

Across 8 payments — averaging $2147.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Eli Lilly$17K

What the payments were for

Food & beverage$7,38897%
Education$2313%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Merck	142	$511,512
Eli Lilly	10	$122,783
Beigene, Ltd.	10	$37,074
Pfizer	14	$16,268
Incyte Corporation	60	$14,811
Amgen	29	$718
Novartis	37	$660
Pharmacyclics LLC, An Abbvie Company	20	$424
AstraZeneca	20	$368
Sanofi	17	$349
Coherus Oncology, Inc.	17	$329
Seagen Inc.	12	$222
Johnson & Johnson	12	$205
Exelixis Inc.	14	$195
GSK	9	$185
E.r. Squibb & Sons, L.L.C.	12	$182
Beigene USA, Inc.	7	$172
Lilly USA, LLC	9	$154
Bristol Myers Squibb	8	$154
Regeneron Healthcare Solutions, Inc.	5	$147
Bayer	8	$138
Eisai Inc.	7	$137
Astellas Pharma US Inc	5	$120
Gilead(2 entities)	6	$119
Puma Biotechnology, Inc.	5	$115
Takeda Pharmaceuticals U.S.A., Inc.	6	$109
AbbVie	4	$91
EMD Serono, Inc.	5	$76
Genentech USA, Inc.	4	$74
AMAG Pharmaceuticals, Inc.	3	$71
Tersera Therapeutics LLC	4	$70
Rigel Pharmaceuticals, Inc.	3	$70
Karyopharm Therapeutics Inc.	3	$67
EUSA Pharma (US) LLC	3	$64
Daiichi Sankyo Inc.	4	$63
Ipsen Biopharmaceuticals, Inc	3	$56
Tolmar Pharmaceuticals, Inc.	3	$54
Myovant Sciences Inc.	2	$46
Blueprint Medicines Corporation	2	$40
Array Biopharma Inc	2	$35
Deciphera Pharmaceuticals Inc.	2	$35
Taiho Oncology, Inc.	1	$34
Verastem, Inc.	2	$25
Morphosys, US Inc.	1	$24
GE HealthCare	1	$24
Sanofi-aventis U.S. LLC	1	$22
Acrotech Biopharma Inc.	1	$22
Tactile Systems Technology Inc	1	$22
Octapharma USA, Inc.	1	$20
Epizyme, Inc.	1	$19
Clovis Oncology, Inc.	2	$18
Aurobindo Pharma USA, Inc.	1	$16
Kyowa Kirin, Inc.	1	$16
Foundation Medicine, Inc.	1	$15
Boehringer Ingelheim	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

KEYTRUDA$115

How this compares

$708,855 in reported general payments places this provider in the 85th percentile of 1,363 hematology & oncology providers in California.

See all hematology & oncology providers in California →

Other hematology & oncology in Escondido

Alain AlgaziSan Francisco$119.2M
David BerzLos Angeles$43.3M
Jonathan GoldmanSanta Monica$35.7M
Omid HamidSanta Monica$23.7M
Nicholas McAndrewLos Angeles$22.9M
Aditya BardiaSanta Monica$22.1M
Joseph TuscanoSacramento$20.4M
Zev WainbergSanta Monica$19.3M
Caitlin CostelloSan Diego$16.9M
Rana McKaySan Diego$15.3M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →